Putting the patient first
Patients are now better informed about their health and highly involved in making decisions about their treatment. As pharmaceutical companies strive to become more patient-centric, there is a need for them to develop the same strong understanding of the patient as they have of the physician.
We offer both custom and syndicated solutions to improve patient understanding.
To facilitate the move towards greater patient centricity we can help with:
Complete understanding of the patient journey from pre-diagnosis to stabilisation, covering the healthcare, disease, emotional and digital pathways, identifying the roadblocks to successful outcomes
Research involving all relevant stakeholders, including physicians, other healthcare professionals, advocacy groups, payers, patients and caregivers, employing observational and behavioural economic techniques to recreate the real-world experience
Research with patients at earlier stages in the product lifecycle, such as in clinical trial design or early-stage market understanding
Recruitment and research with hard-to-reach patients, such as those with rare diseases, or those patients at later stages in their disease, as well as those with long-term chronic conditions
Mobile and digital ethnographic approaches to get you closer to the patient and capture insights in-the-moment
Patient willingness to pay in countries where healthcare expenditure can be out-of-pocket such as the US and emerging markets
Patient segmentation research in order to understand the characteristics of specific groups of patients to target for disease awareness, communication and around the pill support initiatives
Find out more about our customised patient research expertise via our free online resources and find out more about “Living with”, our syndicated patient research reports across a range of chronic diseases and global markets by clicking the boxes below.
Richard has 13 years' experience in healthcare market research consulting. He recently won the EphMRA Presidents Award 2017 for contribution to pharmaceutical market research. Richard also co-authored the Free Thinking white paper, 'Patient centricity: Reality or rhetoric?'.